Skip to main content
Clinical Trials/CTRI/2020/07/026274
CTRI/2020/07/026274RecruitingPhase 1

Effectiveness of Modified Cognitive Processing Therapy in Post-traumatic Stress Disorder:A Preliminary Process Outcome Study

ational Institute of Mental Health and Neurosciences0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • All genders
  • Those who can comprehend the nature of study and provide a written informed consent.
  • Those who meet DSM-5 criteria for PTSD at initial assessment as assessed by PTSD Checklist-5(PCL-5) and Clinician administered PTSD Scale for DSM-5(CAPS-5).
  • The patients should have been stabilized on pharmacological treatment.
  • Those who can read,write and speak kannada or English.

Exclusion Criteria

  • Individuals with current psychotic disorder, bipolar disorder with current episode mania/ severe depressive episode, current substance use/substance dependence not in remission for at least 1 month except Nicotine Use/Dependence.
  • Individuals with serious suicidal risk as assessed on MINI 7.02.
  • Individuals diagnosed with Intellectual Disability(as per the clinical evaluation and file diagnosis).
  • Individuals with neurological illnesses, history of head injury, history suggestive of organicity.
  • Individuals currently undergoing individual/family therapy.
  • Individuals exposed to structured psychological intervention for PTSD in the past 6 months.
  • Those who are not willing to participate in the study.
  • Individuals with ongoing trauma.
  • Individuals with uncontrollable dissociative episodes, panic attacks and those who are not amenable for the therapy.

Investigators

Sponsor
ational Institute of Mental Health and Neurosciences

Similar Trials